These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16188679)

  • 1. Optimizing clotting factor replacement therapy in hemophilia: a global need.
    Srivastava A
    Hematology; 2005; 10 Suppl 1():229-30. PubMed ID: 16188679
    [No Abstract]   [Full Text] [Related]  

  • 2. Replacement therapy with virus-inactivated clotting factor concentrates in patients with severe hemophilia in Heidelberg.
    Zimmermann R; Uhle C; Huth-Kühne A
    Semin Thromb Hemost; 2002 Apr; 28 Suppl 1():75-8. PubMed ID: 12016582
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant blood clotting proteins for hemophilia therapy.
    Limentani SA; Roth DA; Furie BC; Furie B
    Semin Thromb Hemost; 1993; 19(1):62-72. PubMed ID: 8456325
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel drugs to treat hemophilia.
    Valentino LA; Ismael Y; Grygotis M
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):597-613. PubMed ID: 20653467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylactic replacement therapy of hemophilia].
    Nowak K; Zalewska-Szewczyk B; Stolarska M; Bodalski J
    Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):271-2. PubMed ID: 7808949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of inhibitors on the use of clotting factor concentrates].
    Barthels M
    Dtsch Med Wochenschr; 2000 Jan; 125(1-2):17-20. PubMed ID: 10650820
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advances in the field of hemophilia therapy].
    Loeliger EA; Veltkamp JJ
    Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135
    [No Abstract]   [Full Text] [Related]  

  • 8. Clotting factors: Stretching time.
    Savage N
    Nature; 2014 Nov; 515(7528):S162-4. PubMed ID: 25427206
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacovigilance for plasma-derived clotting factor concentrates.
    Tagariello G; Cavallin F; Davoli PG; Gajo GB; De Biasi E; Traldi A
    Lancet; 1993 Dec; 342(8885):1489. PubMed ID: 7902506
    [No Abstract]   [Full Text] [Related]  

  • 10. Global data and haemophilia care trends: commentary.
    Skinner M; Street A
    Haemophilia; 2010 Jan; 16(1):18-9. PubMed ID: 20666846
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment.
    Pierce GF; Lillicrap D; Pipe SW; Vandendriessche T
    J Thromb Haemost; 2007 May; 5(5):901-6. PubMed ID: 17459005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hemophilia with minimal factor replacement in developing countries: role of ancillary therapy.
    Chandy M
    Semin Thromb Hemost; 2005 Nov; 31(5):501-6. PubMed ID: 16276457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of hemophilia treatment].
    Veltkamp JJ
    Ned Tijdschr Geneeskd; 1979 Dec; 123(49):2108-9. PubMed ID: 522912
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hemophilia with prothrombin-complex concentrates.
    Krauss JS
    N Engl J Med; 1980 Dec; 303(24):1418. PubMed ID: 7432394
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C virus seroconversion in a hemophiliac treated exclusively with solvent/detergent-treated clotting factor concentrate.
    Evensen SA; Rollag H; Glomstein A
    Eur J Clin Microbiol Infect Dis; 1995 Jul; 14(7):631-2. PubMed ID: 7588856
    [No Abstract]   [Full Text] [Related]  

  • 16. Bleeding and clotting: new therapies and old issues revisited.
    Lee CA; Aledort LM
    Haemophilia; 2009 Mar; 15(2):592-6. PubMed ID: 19335754
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current treatment of hemophilia].
    van Dijken PJ; Kok AJ; Mauser-Bunschoten EP; Sjamsoedin-Visser EJ
    Tijdschr Ziekenverpl; 1985 Feb; 38(5):144-7. PubMed ID: 3847231
    [No Abstract]   [Full Text] [Related]  

  • 18. [Procoagulant hemoderivatives, hemophilia and immunity].
    Traldi A; Davoli PG; Gajo GB; Tegon G; De Biasi E; Dal Canton A; Cavallin F; Gavioli A; Prosdocimo MT
    Haematologica; 1984; 69(6):771-3. PubMed ID: 6441758
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemophiliac patients in surgery. Implications for perioperative nurses.
    Kleinert D; Cahill-Bordas M; Hilgartner MW
    AORN J; 1990 Oct; 52(4):743-52. PubMed ID: 2241126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status and future prospects for the prophylactic management of hemophilia patients with inhibitor antibodies.
    Teitel JM; Sholzberg M
    Blood Rev; 2013 Mar; 27(2):103-9. PubMed ID: 23452718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.